Lifecore Biomedical
LFCR
97 hedge funds and large institutions have $278M invested in Lifecore Biomedical in 2016 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 29 increasing their positions, 29 reducing their positions, and 6 closing their positions.
50% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 6
1% more funds holding
Funds holding: 96 → 97 (+1)
5% more capital invested
Capital invested by funds: $265M → $278M (+$12.5M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 29
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $405K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
+$7.79M |
| 2 |
TAM
THB Asset Management
Norwalk,
Connecticut
|
+$5.02M |
| 3 |
NIMC
NWQ Investment Management Company
Los Angeles,
California
|
+$4.05M |
| 4 |
CIP
Chartwell Investment Partners
Berywn,
Pennsylvania
|
+$3.07M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$1.61M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Boston Partners
Boston,
Massachusetts
|
-$4.51M |
| 2 |
GC
Guggenheim Capital
Chicago,
Illinois
|
-$1.94M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$1.14M |
| 4 |
HA
Heartland Advisors
Milwaukee,
Wisconsin
|
-$682K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$531K |
LFCR Hedge Fund Activity: Q2 2016 in Review
97 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in Lifecore Biomedical (LFCR) for Q2 2016, worth a combined $278M — up 4.7% from $265M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new LFCR positions and 6 closed out — a net gain of 3 holders — while 29 added to existing stakes and 29 trimmed.
The largest buyer was Franklin Resources, adding an estimated $7.79M. The largest seller was Boston Partners, cutting an estimated $4.51M.
- 97 institutional investors held Lifecore Biomedical (LFCR) as of Q2 2016, up from 96 in Q1 2016.
- Funds reported $278M of Lifecore Biomedical stock for Q2 2016, up 4.7% quarter-over-quarter.
- 9 funds opened new Lifecore Biomedical positions in Q2 2016 and 6 closed out, a net change of +3 holders.
- The largest Lifecore Biomedical buyer in Q2 2016 was Franklin Resources, an estimated $7.79M added.
- The largest Lifecore Biomedical seller in Q2 2016 was Boston Partners, an estimated $4.51M sold.
Based on aggregated 13F filings for Q2 2016.